Koninklijke DSM NV
AEX:DSM
Koninklijke DSM NV
Cash from Financing Activities
Koninklijke DSM NV
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Koninklijke DSM NV
AEX:DSM
|
Cash from Financing Activities
-€645m
|
CAGR 3-Years
21%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
Corbion NV
AEX:CRBN
|
Cash from Financing Activities
-€5.3m
|
CAGR 3-Years
39%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
Akzo Nobel NV
AEX:AKZA
|
Cash from Financing Activities
-€827m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
17%
|
CAGR 10-Years
-5%
|
See Also
What is Koninklijke DSM NV's Cash from Financing Activities?
Cash from Financing Activities
-645m
EUR
Based on the financial report for Dec 31, 2022, Koninklijke DSM NV's Cash from Financing Activities amounts to -645m EUR.
What is Koninklijke DSM NV's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
14%
Over the last year, the Cash from Financing Activities growth was 34%. The average annual Cash from Financing Activities growth rates for Koninklijke DSM NV have been 21% over the past three years , 14% over the past five years .